Insulin-receptor Phosphotyrosyl-protein Phosphatases
Overview
Affiliations
Calmodulin-dependent protein phosphatase has been proposed to be an important phosphotyrosyl-protein phosphatase. The ability of the enzyme to attack autophosphorylated insulin receptor was examined and compared with the known ability of the enzyme to act on autophosphorylated epidermal-growth-factor (EGF) receptor. Purified calmodulin-dependent protein phosphatase was shown to catalyse the complete dephosphorylation of phosphotyrosyl-(insulin receptor). When compared at similar concentrations, 32P-labelled EGF receptor was dephosphorylated at greater than 3 times the rate of 32P-labelled insulin receptor; both dephosphorylations exhibited similar dependence on metal ions and calmodulin. Native phosphotyrosyl-protein phosphatases in cell extracts were also characterized. With rat liver, heart or brain, most (75%) of the native phosphatase activity against both 32P-labelled insulin and EGF receptors was recovered in the particulate fraction of the cell, with only 25% in the soluble fraction. This subcellular distribution contrasts with results of previous studies using artificial substrates, which found most of the phosphotyrosyl-protein phosphatase activity in the soluble fraction of the cell. Properties of particulate and soluble phosphatase activity against 32P-labelled insulin and EGF receptors are reported. The contribution of calmodulin-dependent protein phosphatase activity to phosphotyrosyl-protein phosphatase activity in cell fractions was determined by utilizing the unique metal-ion dependence of calmodulin-dependent protein phosphatase. Whereas Ni2+ (1 mM) markedly activated the calmodulin-dependent protein phosphatase, it was found to inhibit potently both particulate and soluble phosphotyrosyl-protein phosphatase activity. In fractions from rat liver, brain and heart, total phosphotyrosyl-protein phosphatase activity against both 32P-labelled receptors was inhibited by 99.5 +/- 6% (mean +/- S.E.M., 30 observations) by Ni2+. Results of Ni2+ inhibition studies were confirmed by other methods. It is concluded that in cell extracts phosphotyrosyl-protein phosphatases other than calmodulin-dependent protein phosphatase are the major phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatases.
Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.
Drake P, Posner B Mol Cell Biochem. 1998; 182(1-2):79-89.
PMID: 9609117
Insulin receptor internalization and signalling.
Di Guglielmo G, Drake P, Baass P, Authier F, Posner B, Bergeron J Mol Cell Biochem. 1998; 182(1-2):59-63.
PMID: 9609114
Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase.
Estrada C, Gomez C, Martin-Nieto J, de Frutos T, Jimenez A, Villalobo A Biochem J. 1997; 326 ( Pt 2):369-76.
PMID: 9291107 PMC: 1218680. DOI: 10.1042/bj3260369.
Asamoah K, Atkinson P, Carter W, Sale G Biochem J. 1995; 308 ( Pt 3):915-22.
PMID: 8948451 PMC: 1136811. DOI: 10.1042/bj3080915.
In vivo modulation of N-myristoyltransferase activity by orthovanadate.
King M, Pugazhenthi S, Khandelwal R, Sharma R Mol Cell Biochem. 1995; 153(1-2):151-5.
PMID: 8927031 DOI: 10.1007/BF01075931.